MARC details
| 000 -LEADER |
| fixed length control field |
02570nam a2200313Ia 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
| control field |
MX-MdCICY |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20251009160710.0 |
| 040 ## - CATALOGING SOURCE |
| Transcribing agency |
CICY |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (RLIN) |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) |
B-21941 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
251009s9999 xx 000 0 und d |
| 245 10 - TITLE STATEMENT |
| Title |
Anionic polysaccharides as delivery carriers for cancer therapy and theranostics: An overview of significance. |
| 490 0# - SERIES STATEMENT |
| Series statement |
International Journal of Biological Macromolecules, 294, 139211, 2025. |
| 500 ## - GENERAL NOTE |
| General note |
Artículo |
| 520 3# - SUMMARY, ETC. |
| Summary, etc. |
Recently, cancer therapy has witnessed remarkable advancements with a growing focus on precision medicine and targeted drug delivery strategies. The application of anionic polysaccharides has gained traction in various drug delivery systems. Anionic polysaccharides have emerged as promising delivery carriers in cancer therapy and theranostics, offering numerous advantages such as biocompatibility, low toxicity, and the ability to encapsulate and deliver therapeutic agents to tumor sites with high specificity. This review underscores the significance of anionic polysaccharides as essential components of the evolving landscape of cancer therapy and theranostics. These polymers can be tailored to carry a wide range of therapeutic cargo, including chemotherapeutic agents, nucleic acids, and imaging agents. Their negative charge enables electrostatic interactions with positively charged drugs and facilitates the formation of stable nanoparticles, liposomes, or hydrogels for controlled drug release. Additionally, their hydrophilic nature aids in prolonging circulation time, reducing drug degradation, and minimizing off-target effects. Besides, some of them could act as targeting agents or therapeutic compounds that lead to improved therapeutic performance. This review offers valuable information for researchers, clinicians, and biomedical engineers. It provides insights into the recent progress in the applications of anionic polysaccharide-based delivery platforms in cancer theranostics to transform patient outcomes. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
ANIONIC POLYSACCHARIDES |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
CANCER NANOMEDICINE |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
THERANOSTICS |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
BIOPOLYMER |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name entry element |
TARGETED DRUG DELIVERY |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Sivakumar, P. M. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Zarepour, A. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Akhter, S. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Perumal, G. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Khosravi, A. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Balasekar, P. |
| 700 12 - ADDED ENTRY--PERSONAL NAME |
| Personal name |
Zarrabi, A. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
| Uniform Resource Identifier |
<a href="https://drive.google.com/file/d/1WpyiVlUQQTtzBKQWf0Uu3ie2o4iMzQMc/view?usp=drive_link">https://drive.google.com/file/d/1WpyiVlUQQTtzBKQWf0Uu3ie2o4iMzQMc/view?usp=drive_link</a> |
| Public note |
Para ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Source of classification or shelving scheme |
Clasificación local |
| Koha item type |
Documentos solicitados |